Lower mortality in cancer patients treated with low-molecular-weight versus standard heparin

Lancet. 1992 Jun 13;339(8807):1476. doi: 10.1016/0140-6736(92)92064-m.
No abstract available

Publication types

  • Letter

MeSH terms

  • Heparin, Low-Molecular-Weight / therapeutic use*
  • Humans
  • Neoplasms / drug therapy
  • Neoplasms / mortality*

Substances

  • Heparin, Low-Molecular-Weight